Skip to main content

Want a detailed portfolio tracker?

Geron (GERN) P/E (2006 - 2026)

Geron (GERN) P/E from Mar 31, 2006 to Jun 3, 2026. The TTM Geron (GERN) P/E is -11.12. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Geron (GERN)

YearP/EChange
2026-11.12+8.38%
2025-10.26-20.58%
2024-12.92+109.23%
2023-6.17-8.57%
2022-6.75+96.14%
2021-3.44-38.94%
2020-5.64+48.04%
2019-3.81-41.32%
2018-6.49-34.39%
2017-9.89-11.13%
2016-11.13-98.93%
2015-1.04K+7358.93%
2014-13.99-11.64%
2013-15.83+509.27%
2012-2.60+98.79%
2011-1.31-71.07%
2010-4.52-34.98%
2009-6.95+18.06%
2008-5.88-49.30%
2007-11.61-43.47%
2006-20.53N/A

Comparison Geron (GERN) P/E with competitors

Geron (GERN) P/E is -11.12.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.92%
ENLVEnlivex Therapeutics Ltd0.15-101.35%
FGENFibroGen Inc0.24-102.16%
TRAWTraws Pharma Inc0.47-104.25%
FBIOFortress Biotech Inc0.71-106.35%
CHRSCoherus Biosciences Inc0.98-108.80%
ORMPOramed Pharmaceuticals Inc1.47-113.25%
AGENAgenus Inc2.05-118.42%
VIVSVivoSim Labs Inc2.54-122.80%
INVAInnoviva Inc3.19-128.67%
CRMDCorMedix Inc3.65-132.78%
ABEOAbeona Therapeutics Inc4.20-137.81%
VXRTVaxart Inc4.26-138.32%
CVACCureVac N.V.4.45-139.98%
SRPTSarepta Therapeutics Inc4.62-141.58%
GLPGGalapagos NV4.86-143.69%
RIGLRigel Pharmaceuticals4.92-144.24%
ZVRAZevra Therapeutics Inc4.97-144.73%
ABUSArbutus Biopharma Corp5.69-151.20%
CGENCompugen Ltd7.38-166.40%
AUPHAurinia Pharmaceuticals Inc9.25-183.19%
ACADAcadia Pharmaceuticals Inc9.59-186.22%
OMEROmeros Corporation9.88-188.88%
PLXProtalix BioTherapeutics Inc9.91-189.11%
SPROSpero Therapeutics Inc10.73-196.53%
ADMAAdma Biologics Inc11.33-201.89%
SVASinovac Biotech Ltd11.44-202.84%
TBPHTheravance Biopharma Inc11.78-205.90%
HRMYHarmony Biosciences Holdings Inc12.18-209.53%
TGTXTG Therapeutics Inc13.18-218.52%
INCYIncyte Corp13.38-220.34%
SABSSAB Biotherapeutics Inc14.06-226.41%
XOMAXOMA Corp14.95-234.39%
REGNRegeneron Pharmaceuticals Inc14.98-234.71%
PBYIPuma Biotechnology Inc15.05-235.34%
EXELExelixis Inc15.79-242.03%
NAGENiagen Bioscience Inc16.35-247.07%
CPRXCatalyst Pharmaceuticals Inc17.34-255.97%
MDXGMimedx Group Inc17.38-256.25%
ARGXArgen X SE23.07-307.47%
HALOHalozyme Therapeutics Inc23.20-308.63%
XOMAOXOMA Corp25.34-327.91%
VRTXVertex Pharmaceuticals Inc25.66-330.71%
XOMAPXOMA Corp25.67-330.84%
CTMXCytomX Therapeutics Inc25.70-331.09%
ASNDAscendis Pharma A/S26.35-336.99%
RPRXRoyalty Pharma plc - Class A27.50-347.25%
SLNOSoleno Therapeutics Inc29.02-360.92%
LGNDLigand Pharmaceuticals Inc - Class B30.19-371.45%
BMRNBiomarin Pharmaceutical Inc37.51-437.28%
APLSApellis Pharmaceuticals Inc39.02-450.90%
KRYSKrystal Biotech Inc39.70-456.98%
GMABGenmab40.20-461.53%
ONCBeiGene Ltd67.03-702.74%
TECHBio-Techne Corp68.59-716.84%
VCELVericel Corp80.63-825.06%
PHARPharming Group N.V.87.74-889.00%
ALNYAlnylam Pharmaceuticals Inc124.93-1223.46%
TLXTelix Pharmaceuticals Ltd139.89-1357.96%
CORTCorcept Therapeutics Inc158.39-1524.31%